ECHO+: Improving access to hepatitis C care within Indigenous communities in Alberta, Canada.

Canadian liver journal Pub Date : 2022-05-09 eCollection Date: 2022-01-01 DOI:10.3138/canlivj-2021-0027
Kate Pr Dunn, Kienan P Williams, Cari E Egan, Melissa L Potestio, Samuel S Lee
{"title":"ECHO+: Improving access to hepatitis C care within Indigenous communities in Alberta, Canada.","authors":"Kate Pr Dunn, Kienan P Williams, Cari E Egan, Melissa L Potestio, Samuel S Lee","doi":"10.3138/canlivj-2021-0027","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Indigenous populations experience higher rates of hepatitis C virus (HCV) infections in Canada. The Extension for Community Health Outcomes+ (ECHO+) telehealth model was implemented in Alberta to support HCV screening and treatment, using Zoom technology to support Indigenous patient access to specialist care closer to home. Our goal was to expand this program to more Indigenous communities in Alberta, using various Indigenous-led or co-designed methods.</p><p><strong>Methods: </strong>The ECHO+ team implemented a Two-Eyed Seeing framework, incorporating Indigenous wholistic approaches alongside Western treatment. This approach works with principles of respect, reciprocity, and relationality. The ECHO+ team identified Indigenous-specific challenges, including access to liver specialist care, HCV awareness, stigma, barriers to screening and lack of culturally relevant approaches.</p><p><strong>Results: </strong>Access to HCV care via this program significantly increased HCV antiviral use in the past 5 years. Key lessons learned include Indigenous-led relationship building and development of project outputs in response to community needs influences impact and increases relevant changes increasing access to HCV care. Implementation of ECHO+ was carried out through biweekly telehealth sessions, problem solving in partnership with Indigenous communities, increased HCV awareness, and flexibility resulting from the impacts of COVID-19.</p><p><strong>Conclusion: </strong>Improving Indigenous patient lives and reducing inequity requires supporting local primary health care providers to create and sustain integrated HCV prevention, diagnosis, treatment, and support services within a culturally safe and reciprocal model. ECHO+ uses telehealth and culturally appropriate methodology and interventions alongside multiple stakeholder collaborations to improve health outcomes for HCV.</p>","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":" ","pages":"113-123"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236587/pdf/canlivj-2021-0027.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian liver journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3138/canlivj-2021-0027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Indigenous populations experience higher rates of hepatitis C virus (HCV) infections in Canada. The Extension for Community Health Outcomes+ (ECHO+) telehealth model was implemented in Alberta to support HCV screening and treatment, using Zoom technology to support Indigenous patient access to specialist care closer to home. Our goal was to expand this program to more Indigenous communities in Alberta, using various Indigenous-led or co-designed methods.

Methods: The ECHO+ team implemented a Two-Eyed Seeing framework, incorporating Indigenous wholistic approaches alongside Western treatment. This approach works with principles of respect, reciprocity, and relationality. The ECHO+ team identified Indigenous-specific challenges, including access to liver specialist care, HCV awareness, stigma, barriers to screening and lack of culturally relevant approaches.

Results: Access to HCV care via this program significantly increased HCV antiviral use in the past 5 years. Key lessons learned include Indigenous-led relationship building and development of project outputs in response to community needs influences impact and increases relevant changes increasing access to HCV care. Implementation of ECHO+ was carried out through biweekly telehealth sessions, problem solving in partnership with Indigenous communities, increased HCV awareness, and flexibility resulting from the impacts of COVID-19.

Conclusion: Improving Indigenous patient lives and reducing inequity requires supporting local primary health care providers to create and sustain integrated HCV prevention, diagnosis, treatment, and support services within a culturally safe and reciprocal model. ECHO+ uses telehealth and culturally appropriate methodology and interventions alongside multiple stakeholder collaborations to improve health outcomes for HCV.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
ECHO+:改善加拿大艾伯塔省土著社区内丙型肝炎护理的可及性。
背景:在加拿大,原住民的丙型肝炎病毒(HCV)感染率较高。艾伯塔省实施了 "社区健康成果扩展+"(ECHO+)远程医疗模式,利用 Zoom 技术为丙型肝炎病毒筛查和治疗提供支持,帮助土著患者就近获得专科医疗服务。我们的目标是利用各种由土著主导或共同设计的方法,将该计划推广到艾伯塔省更多的土著社区:ECHO+ 团队实施了 "双眼观察"(Two-Eyed Seeing)框架,将原住民的整体治疗方法与西方治疗方法相结合。这种方法遵循尊重、互惠和关系性原则。ECHO+ 团队确定了土著居民面临的具体挑战,包括获得肝脏专科护理、对丙型肝炎病毒的认识、耻辱感、筛查障碍以及缺乏与文化相关的方法:结果:在过去 5 年中,通过该计划获得的丙型肝炎病毒治疗大大增加了丙型肝炎病毒抗病毒药物的使用。获得的主要经验包括:由土著人主导的关系建设以及根据社区需求开发项目产出,这些都会产生影响并增加相关变化,从而提高 HCV 护理的可及性。ECHO+ 的实施是通过每两周一次的远程医疗会议、与土著社区合作解决问题、提高对 HCV 的认识以及 COVID-19 的影响所带来的灵活性来实现的:结论:要改善原住民患者的生活并减少不公平现象,就必须支持当地初级卫生保健提供者在文化安全和互惠的模式下创建并维持综合的 HCV 预防、诊断、治疗和支持服务。ECHO+ 采用远程医疗和文化上适当的方法和干预措施,并与多个利益相关者合作,以改善丙型肝炎病毒的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Population-level cascade of care for hepatitis C in Newfoundland and Labrador Isolated hepatic sarcoidosis: A case series Breaking boundaries: Unraveling metabolic dysfunction-associated steatotic liver disease in children of India and Canada Exploring autoantibodies as predictors of severe fibrosis or cirrhosis in metabolic dysfunction associated steatotic liver disease Impact of statins in the liver: A bane or a boon?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1